Description
May 1, 2026
CAP Statement on Introduction of Medicare Local Coverage Reform Bill
Preparing for PAMA Reporting in 2026 (CAP)
Digital Pathology 101: Packing Your Bags for a Digital Pathology Journey (CAP)
CAP Podcast: The Hardest Part of Digital Pathology Isn’t Digital
Digital Pathology Topic Center | College of American Pathologists
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
The CAP supports a new push to reform Medicare coverage decisions, diagnosing the cause of a major kidney problem, and Digital Pathology 101. These stories and more, coming up next. This is Path News Network's Daily Edition from the College of American Pathologists. I'm Nick Lanyi. It's Friday, May 1st. The CAP this week declared support for new bipartisan legislation in Congress that would reform Medicare's process for approving or denying local coverage determinations, or LCDs. In a statement, CAP President Jim Zhai said the bill would improve the LCD process by strengthening transparency, increasing meaningful stakeholder engagement, and ensuring coverage policies are guided by qualified medical experts and completed in a timely manner. The bill, House Resolution 8500, would help protect patient access to crucial diagnostic tests while safeguarding physicians' ability to make clinical judgments. Advanced immunostaining can provide new insights into acute interstitial nephritis, or AIN, according to a new study in CEN Case Reports. AIN is a severe kidney inflammation that's usually caused by drug interactions, but it's also associated with acute pyelonephritis, an E. coli infection that spreads to the kidney from the bladder. Distinguishing between the two is important, as the treatments differ. In the study, researchers from Japan used advanced staining to examine a kidney biopsy from a woman diagnosed with drug-induced AIN using routine histology. They detected the CK7 biomarker confined to the kidney's distal tubes, indicating pyelonephritis but not drug-induced AIN. The study suggests that immunostaining could lead to more effective treatment. New private payer data reporting rules for hospitals, physician offices, and independent laboratories go into effect today. While payment reductions under the Protecting Access to Medicare Act are on hold, qualifying organizations must report private payer rate data for the first six months of 2025 to the Centers for Medicare and Medicaid Services between now and July 31. CMS will use the data to calculate future Medicare payment rates under the clinical laboratory fee schedule. See the CAP website for resources about the reporting requirements. including a two-pager with frequently asked questions. And finally, the CAP's Digital and Computational Pathology Committee released a new Digital Pathology 101 guide to help pathologists and laboratories who are starting to adopt digital pathology tools. The guide provides a general framework for approaching such a project, along with key considerations for each stage of the process. in a new CAP podcast. Two committee members discussed the new guide and some of the challenges involved with going digital. Dr. Jordan Olson, Chief Medical Officer of HNL Lab Medicine in Allentown, Pennsylvania, and Dr. Meredith Herman, a pathology resident at the University of Michigan. Here's Dr. Olson:
Questions like what scanners should I buy? What monitors are the best? What image management system makes the most sense? are common in folks who are starting to look at digital pathology. What we wanted to do is put together a guide that not only answers those questions, but also helps people through the entire digital pathology journey, from acquisition to post-go-live governance.
The doctors emphasized that technology isn't the only issue.
Change management is at the heart of any digital pathology implementation. We can talk about scanners. We can talk about image management systems. We can talk about AI. All of those things are important. But if you don't get the pathologists, if you don't get the technologists, if you don't get everyone involved in the surgical pathology process buy-in, you're not going to have a successful implementation.
Dr. Herman, who went through a digital transition as a trainee at the University of Michigan, said the process is worth it. Improved workflow, Easier slide retrieval and storage, better annotation, more opportunity for collaboration. but it requires the right attitude.
I think the biggest thing is to be open-minded and flexible. There's going to be a lot of challenges that come up with the process. Being patient is also very key. So those are a few of the key lessons, but you're going to encounter some inconveniences with some scanning issues, or you might have things that come up with slides not. being scanned properly or something went awry in the process and just being flexible and patient and working with your team to figure out why those things happen so they don't happen again. And, you know, I think it's just a persistent attitude you have to keep having every single day until it's fully implemented.
You can find the podcast and the new guide at the CAP website or in our show notes. And that's it for today. If you liked today's podcast, spread the word on social media. And if you'd like to recommend a story for us to cover, write to us at stories at cap.org. We'll be back Monday at 5 a.m. Eastern for another episode of The Daily Edition. I'm Nick Lanyi. Have a wonderful weekend.
Description
May 1, 2026
CAP Statement on Introduction of Medicare Local Coverage Reform Bill
Preparing for PAMA Reporting in 2026 (CAP)
Digital Pathology 101: Packing Your Bags for a Digital Pathology Journey (CAP)
CAP Podcast: The Hardest Part of Digital Pathology Isn’t Digital
Digital Pathology Topic Center | College of American Pathologists
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
The CAP supports a new push to reform Medicare coverage decisions, diagnosing the cause of a major kidney problem, and Digital Pathology 101. These stories and more, coming up next. This is Path News Network's Daily Edition from the College of American Pathologists. I'm Nick Lanyi. It's Friday, May 1st. The CAP this week declared support for new bipartisan legislation in Congress that would reform Medicare's process for approving or denying local coverage determinations, or LCDs. In a statement, CAP President Jim Zhai said the bill would improve the LCD process by strengthening transparency, increasing meaningful stakeholder engagement, and ensuring coverage policies are guided by qualified medical experts and completed in a timely manner. The bill, House Resolution 8500, would help protect patient access to crucial diagnostic tests while safeguarding physicians' ability to make clinical judgments. Advanced immunostaining can provide new insights into acute interstitial nephritis, or AIN, according to a new study in CEN Case Reports. AIN is a severe kidney inflammation that's usually caused by drug interactions, but it's also associated with acute pyelonephritis, an E. coli infection that spreads to the kidney from the bladder. Distinguishing between the two is important, as the treatments differ. In the study, researchers from Japan used advanced staining to examine a kidney biopsy from a woman diagnosed with drug-induced AIN using routine histology. They detected the CK7 biomarker confined to the kidney's distal tubes, indicating pyelonephritis but not drug-induced AIN. The study suggests that immunostaining could lead to more effective treatment. New private payer data reporting rules for hospitals, physician offices, and independent laboratories go into effect today. While payment reductions under the Protecting Access to Medicare Act are on hold, qualifying organizations must report private payer rate data for the first six months of 2025 to the Centers for Medicare and Medicaid Services between now and July 31. CMS will use the data to calculate future Medicare payment rates under the clinical laboratory fee schedule. See the CAP website for resources about the reporting requirements. including a two-pager with frequently asked questions. And finally, the CAP's Digital and Computational Pathology Committee released a new Digital Pathology 101 guide to help pathologists and laboratories who are starting to adopt digital pathology tools. The guide provides a general framework for approaching such a project, along with key considerations for each stage of the process. in a new CAP podcast. Two committee members discussed the new guide and some of the challenges involved with going digital. Dr. Jordan Olson, Chief Medical Officer of HNL Lab Medicine in Allentown, Pennsylvania, and Dr. Meredith Herman, a pathology resident at the University of Michigan. Here's Dr. Olson:
Questions like what scanners should I buy? What monitors are the best? What image management system makes the most sense? are common in folks who are starting to look at digital pathology. What we wanted to do is put together a guide that not only answers those questions, but also helps people through the entire digital pathology journey, from acquisition to post-go-live governance.
The doctors emphasized that technology isn't the only issue.
Change management is at the heart of any digital pathology implementation. We can talk about scanners. We can talk about image management systems. We can talk about AI. All of those things are important. But if you don't get the pathologists, if you don't get the technologists, if you don't get everyone involved in the surgical pathology process buy-in, you're not going to have a successful implementation.
Dr. Herman, who went through a digital transition as a trainee at the University of Michigan, said the process is worth it. Improved workflow, Easier slide retrieval and storage, better annotation, more opportunity for collaboration. but it requires the right attitude.
I think the biggest thing is to be open-minded and flexible. There's going to be a lot of challenges that come up with the process. Being patient is also very key. So those are a few of the key lessons, but you're going to encounter some inconveniences with some scanning issues, or you might have things that come up with slides not. being scanned properly or something went awry in the process and just being flexible and patient and working with your team to figure out why those things happen so they don't happen again. And, you know, I think it's just a persistent attitude you have to keep having every single day until it's fully implemented.
You can find the podcast and the new guide at the CAP website or in our show notes. And that's it for today. If you liked today's podcast, spread the word on social media. And if you'd like to recommend a story for us to cover, write to us at stories at cap.org. We'll be back Monday at 5 a.m. Eastern for another episode of The Daily Edition. I'm Nick Lanyi. Have a wonderful weekend.
Share
Embed
You may also like
Description
May 1, 2026
CAP Statement on Introduction of Medicare Local Coverage Reform Bill
Preparing for PAMA Reporting in 2026 (CAP)
Digital Pathology 101: Packing Your Bags for a Digital Pathology Journey (CAP)
CAP Podcast: The Hardest Part of Digital Pathology Isn’t Digital
Digital Pathology Topic Center | College of American Pathologists
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
The CAP supports a new push to reform Medicare coverage decisions, diagnosing the cause of a major kidney problem, and Digital Pathology 101. These stories and more, coming up next. This is Path News Network's Daily Edition from the College of American Pathologists. I'm Nick Lanyi. It's Friday, May 1st. The CAP this week declared support for new bipartisan legislation in Congress that would reform Medicare's process for approving or denying local coverage determinations, or LCDs. In a statement, CAP President Jim Zhai said the bill would improve the LCD process by strengthening transparency, increasing meaningful stakeholder engagement, and ensuring coverage policies are guided by qualified medical experts and completed in a timely manner. The bill, House Resolution 8500, would help protect patient access to crucial diagnostic tests while safeguarding physicians' ability to make clinical judgments. Advanced immunostaining can provide new insights into acute interstitial nephritis, or AIN, according to a new study in CEN Case Reports. AIN is a severe kidney inflammation that's usually caused by drug interactions, but it's also associated with acute pyelonephritis, an E. coli infection that spreads to the kidney from the bladder. Distinguishing between the two is important, as the treatments differ. In the study, researchers from Japan used advanced staining to examine a kidney biopsy from a woman diagnosed with drug-induced AIN using routine histology. They detected the CK7 biomarker confined to the kidney's distal tubes, indicating pyelonephritis but not drug-induced AIN. The study suggests that immunostaining could lead to more effective treatment. New private payer data reporting rules for hospitals, physician offices, and independent laboratories go into effect today. While payment reductions under the Protecting Access to Medicare Act are on hold, qualifying organizations must report private payer rate data for the first six months of 2025 to the Centers for Medicare and Medicaid Services between now and July 31. CMS will use the data to calculate future Medicare payment rates under the clinical laboratory fee schedule. See the CAP website for resources about the reporting requirements. including a two-pager with frequently asked questions. And finally, the CAP's Digital and Computational Pathology Committee released a new Digital Pathology 101 guide to help pathologists and laboratories who are starting to adopt digital pathology tools. The guide provides a general framework for approaching such a project, along with key considerations for each stage of the process. in a new CAP podcast. Two committee members discussed the new guide and some of the challenges involved with going digital. Dr. Jordan Olson, Chief Medical Officer of HNL Lab Medicine in Allentown, Pennsylvania, and Dr. Meredith Herman, a pathology resident at the University of Michigan. Here's Dr. Olson:
Questions like what scanners should I buy? What monitors are the best? What image management system makes the most sense? are common in folks who are starting to look at digital pathology. What we wanted to do is put together a guide that not only answers those questions, but also helps people through the entire digital pathology journey, from acquisition to post-go-live governance.
The doctors emphasized that technology isn't the only issue.
Change management is at the heart of any digital pathology implementation. We can talk about scanners. We can talk about image management systems. We can talk about AI. All of those things are important. But if you don't get the pathologists, if you don't get the technologists, if you don't get everyone involved in the surgical pathology process buy-in, you're not going to have a successful implementation.
Dr. Herman, who went through a digital transition as a trainee at the University of Michigan, said the process is worth it. Improved workflow, Easier slide retrieval and storage, better annotation, more opportunity for collaboration. but it requires the right attitude.
I think the biggest thing is to be open-minded and flexible. There's going to be a lot of challenges that come up with the process. Being patient is also very key. So those are a few of the key lessons, but you're going to encounter some inconveniences with some scanning issues, or you might have things that come up with slides not. being scanned properly or something went awry in the process and just being flexible and patient and working with your team to figure out why those things happen so they don't happen again. And, you know, I think it's just a persistent attitude you have to keep having every single day until it's fully implemented.
You can find the podcast and the new guide at the CAP website or in our show notes. And that's it for today. If you liked today's podcast, spread the word on social media. And if you'd like to recommend a story for us to cover, write to us at stories at cap.org. We'll be back Monday at 5 a.m. Eastern for another episode of The Daily Edition. I'm Nick Lanyi. Have a wonderful weekend.
Description
May 1, 2026
CAP Statement on Introduction of Medicare Local Coverage Reform Bill
Preparing for PAMA Reporting in 2026 (CAP)
Digital Pathology 101: Packing Your Bags for a Digital Pathology Journey (CAP)
CAP Podcast: The Hardest Part of Digital Pathology Isn’t Digital
Digital Pathology Topic Center | College of American Pathologists
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
The CAP supports a new push to reform Medicare coverage decisions, diagnosing the cause of a major kidney problem, and Digital Pathology 101. These stories and more, coming up next. This is Path News Network's Daily Edition from the College of American Pathologists. I'm Nick Lanyi. It's Friday, May 1st. The CAP this week declared support for new bipartisan legislation in Congress that would reform Medicare's process for approving or denying local coverage determinations, or LCDs. In a statement, CAP President Jim Zhai said the bill would improve the LCD process by strengthening transparency, increasing meaningful stakeholder engagement, and ensuring coverage policies are guided by qualified medical experts and completed in a timely manner. The bill, House Resolution 8500, would help protect patient access to crucial diagnostic tests while safeguarding physicians' ability to make clinical judgments. Advanced immunostaining can provide new insights into acute interstitial nephritis, or AIN, according to a new study in CEN Case Reports. AIN is a severe kidney inflammation that's usually caused by drug interactions, but it's also associated with acute pyelonephritis, an E. coli infection that spreads to the kidney from the bladder. Distinguishing between the two is important, as the treatments differ. In the study, researchers from Japan used advanced staining to examine a kidney biopsy from a woman diagnosed with drug-induced AIN using routine histology. They detected the CK7 biomarker confined to the kidney's distal tubes, indicating pyelonephritis but not drug-induced AIN. The study suggests that immunostaining could lead to more effective treatment. New private payer data reporting rules for hospitals, physician offices, and independent laboratories go into effect today. While payment reductions under the Protecting Access to Medicare Act are on hold, qualifying organizations must report private payer rate data for the first six months of 2025 to the Centers for Medicare and Medicaid Services between now and July 31. CMS will use the data to calculate future Medicare payment rates under the clinical laboratory fee schedule. See the CAP website for resources about the reporting requirements. including a two-pager with frequently asked questions. And finally, the CAP's Digital and Computational Pathology Committee released a new Digital Pathology 101 guide to help pathologists and laboratories who are starting to adopt digital pathology tools. The guide provides a general framework for approaching such a project, along with key considerations for each stage of the process. in a new CAP podcast. Two committee members discussed the new guide and some of the challenges involved with going digital. Dr. Jordan Olson, Chief Medical Officer of HNL Lab Medicine in Allentown, Pennsylvania, and Dr. Meredith Herman, a pathology resident at the University of Michigan. Here's Dr. Olson:
Questions like what scanners should I buy? What monitors are the best? What image management system makes the most sense? are common in folks who are starting to look at digital pathology. What we wanted to do is put together a guide that not only answers those questions, but also helps people through the entire digital pathology journey, from acquisition to post-go-live governance.
The doctors emphasized that technology isn't the only issue.
Change management is at the heart of any digital pathology implementation. We can talk about scanners. We can talk about image management systems. We can talk about AI. All of those things are important. But if you don't get the pathologists, if you don't get the technologists, if you don't get everyone involved in the surgical pathology process buy-in, you're not going to have a successful implementation.
Dr. Herman, who went through a digital transition as a trainee at the University of Michigan, said the process is worth it. Improved workflow, Easier slide retrieval and storage, better annotation, more opportunity for collaboration. but it requires the right attitude.
I think the biggest thing is to be open-minded and flexible. There's going to be a lot of challenges that come up with the process. Being patient is also very key. So those are a few of the key lessons, but you're going to encounter some inconveniences with some scanning issues, or you might have things that come up with slides not. being scanned properly or something went awry in the process and just being flexible and patient and working with your team to figure out why those things happen so they don't happen again. And, you know, I think it's just a persistent attitude you have to keep having every single day until it's fully implemented.
You can find the podcast and the new guide at the CAP website or in our show notes. And that's it for today. If you liked today's podcast, spread the word on social media. And if you'd like to recommend a story for us to cover, write to us at stories at cap.org. We'll be back Monday at 5 a.m. Eastern for another episode of The Daily Edition. I'm Nick Lanyi. Have a wonderful weekend.
Share
Embed
You may also like